Products for Research Use Only
RegisterLogin

KM02894

CAT: 0804-HY-W276106-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W276106-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1].
CAS Number
116850-74-9
UNSPSC
12352005
Hazard Statement
H301
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/km02894.html
Purity
99.31
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C) |DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CNC(NNC(C1=CC=CS1)=O)=S
Molecular Formula
C7H9N3OS2
Molecular Weight
215.30
Precautions
P264-P270-P330-P405-P501
References & Citations
[1]Fazzari J, et.al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
T77581KM02894

Popular Products